M&A Deal Summary |
|
---|---|
Date | 2021-08-05 |
Target | Pinnacle 21 |
Sector | Software |
Buyer(s) | Certara |
Deal Type | Add-on Acquisition |
Deal Value | 310M USD |
Advisor(s) | Fairmount Partners (Financial) Cozen O'Connor (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2008 |
Sector | Life Science |
Employees | 1,338 |
Revenue | 354M USD (2023) |
Certara engages in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes. Certara was founded in 2008 and is headquartered in Princeton, New Jersey.
DEAL STATS | # |
---|---|
Overall | 8 of 11 |
Sector (Software) | 2 of 4 |
Type (Add-on Acquisition) | 8 of 11 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 4 of 6 |
Year (2021) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-09-13 |
Pirana Software & Consulting BV
Netherlands Pirana Software & Consulting BV is a flexible, extendible pharmacometrics workbench that provides modelers with structure, tools and a graphical user interface to facilitate the iterative processes used to create pharmacometric models and perform simulations. Pirana Software & Consulting was founded in 2011 and is based in Netherlands. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-01-04 |
Vyasa
Newburyport, Massachusetts, United States Vyasa provides scalable deep-learning software which allows life sciences organizations to perform predictions and answer complex questions across structured and unstructured bio-medical information. Vyasa was founded in 2017 and is based in Newburyport, Massachusetts. |
Buy | - |